{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:11:56Z","timestamp":1761977516994,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ajg.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T18:05:56Z","timestamp":1381428356000},"page":"94-98","source":"Crossref","is-referenced-by-count":10,"title":["Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment"],"prefix":"10.1016","volume":"14","author":[{"given":"Maissa","family":"El Raziky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"El akel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Khatab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaimaa","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajg.2013.08.005_b0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004836-200103000-00014","article-title":"Clinical; virologic and pathologic significance of elevated serum alpha fetoprotein levels in patients with chronic C","volume":"32","author":"Chu","year":"2001","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.ajg.2013.08.005_b0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0016-5085(90)90037-2","article-title":"Hereditary persistence of alpha-fetoprotein","volume":"98","author":"Greenberg","year":"1990","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajg.2013.08.005_b0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1089-3261(05)70158-6","article-title":"The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma","volume":"5","author":"Johnson","year":"2001","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.ajg.2013.08.005_b0020","first-page":"295","article-title":"Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography","volume":"96","author":"Barletta","year":"2005","journal-title":"Recenti Prog Med"},{"issue":"5","key":"10.1016\/j.ajg.2013.08.005_b0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1572-0241.2004.04152.x","article-title":"Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma","volume":"99","author":"Hu","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ajg.2013.08.005_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ajg.2013.08.005_b0035","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","article-title":"Early recognition of hepatocellular carcinoma based on altered profiles of alphafetoprotein","volume":"328","author":"Sato","year":"1993","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ajg.2013.08.005_b0040","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199506013322202","article-title":"Clinical outcomes after transfusion-associated hepatitis C","volume":"32","author":"Tong","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajg.2013.08.005_b0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"(HALT-C trial group): serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2013.08.005_b0050","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/315786","article-title":"Genetic epidemiology of hepatitis C virus throughout Egypt","volume":"182","author":"Ray","year":"2000","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.ajg.2013.08.005_b0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2893.2009.01115.x","article-title":"Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality","volume":"16","author":"Lehman","year":"2009","journal-title":"J Viral Hepat"},{"issue":"9207","key":"10.1016\/j.ajg.2013.08.005_b0060","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parentral antischistosomal theapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ajg.2013.08.005_b0065","unstructured":"Zakaria S, El-Raziky M, Fouad R, et al. Seroprevalence of viral hepatitis markers in rural and semirural Egyptian districts. 10th International Symposium on Viral Hepatitis and Liver Diseases, Atlanta, USA. Anti-viral therapy 2000;5:1, F12, abstr F020."},{"issue":"3","key":"10.1016\/j.ajg.2013.08.005_b0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0035-9203(97)90070-5","article-title":"Hepatitis C antibody prevalence in blood donors in different governorates in Egypt","volume":"91","author":"Arthur","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3\u20134","key":"10.1016\/j.ajg.2013.08.005_b0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2001.64.147","article-title":"Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study","volume":"64","author":"Darwish","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"1 pt1","key":"10.1016\/j.ajg.2013.08.005_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR cooperative study group","volume":"20","author":"Bedossa","year":"1994","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ajg.2013.08.005_b0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.ajg.2013.08.005_b0090","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.ajg.2013.08.005_b0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0168-8278(99)80394-8","article-title":"Definition of response to antiviral therapy in chronic hepatitis C","volume":"31","author":"Craxi","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2013.08.005_b0100","unstructured":"NIH Consensus Statement on Management of Hepatitis C: NIH Consens State Sci Statements 2002;10\u201312;19(3):1\u201346."},{"issue":"12","key":"10.1016\/j.ajg.2013.08.005_b0105","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1111\/j.1572-0241.1998.00703.x","article-title":"Serum alpha fetoprotein levels and liver histology in patients with chronic hepatitis C","volume":"93","author":"Bayati","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajg.2013.08.005_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2005.11.010","article-title":"American Gastroenterological Association Technical Review on the management of hepatitis C","volume":"130","author":"Dienstag","year":"2006","journal-title":"Gastroenterology"},{"issue":"3(6)","key":"10.1016\/j.ajg.2013.08.005_b0125","doi-asserted-by":"crossref","first-page":"e2391","DOI":"10.1371\/journal.pone.0002391","article-title":"Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype","volume":"11","author":"Abdoul","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ajg.2013.08.005_b0130","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1478-3231.2008.01750.x","article-title":"Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C","volume":"28","author":"Gad","year":"2008","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.ajg.2013.08.005_b0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/135965350701200506","article-title":"Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C","volume":"12","author":"Males","year":"2007","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.ajg.2013.08.005_b0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0929-6646(09)60054-1","article-title":"Clinical Implications of alpha-fetoprotein in chronic hepatitis C","volume":"108","author":"Tai","year":"2009","journal-title":"J Formosan Med Assoc Taiwan yi zhi"},{"issue":"5","key":"10.1016\/j.ajg.2013.08.005_b0145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1440-1746.2007.04898.x","article-title":"Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alpha 2a \u2013 ribavirin combination therapy","volume":"22","author":"Chen","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2013.08.005_b0150","first-page":"154","article-title":"Study of alpha fetoprotein, ferritin levels and liver ultrasonic findings in hemodialysis patients possessing hepatitis C virus antibodies in Tabriz","volume":"22","author":"Seifi","year":"2006","journal-title":"Pak J Med Sci"},{"issue":"1","key":"10.1016\/j.ajg.2013.08.005_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0256-4947.51810","article-title":"Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects","volume":"29","author":"Abdo","year":"2009","journal-title":"Ann Saudi Med"},{"issue":"1","key":"10.1016\/j.ajg.2013.08.005_b0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0256-4947.51816","article-title":"Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4","volume":"29","author":"Al Ashgar","year":"2009","journal-title":"Ann Saudi Med"},{"issue":"4","key":"10.1016\/j.ajg.2013.08.005_b0165","first-page":"12","article-title":"Efficacy of antiviral treatment with interferon alpha and ribavirin in \u201cdifficult-to-treat\u201d chronic hepatitis C patients","volume":"3","author":"Jurczyk","year":"2007","journal-title":"Exp Clin Hepatol"},{"issue":"12","key":"10.1016\/j.ajg.2013.08.005_b0170","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1023\/A:1021044803279","article-title":"Normalization of markedly elevated alpha-fetoprotein in a virologic non-responder with HCV-related cirrhosis","volume":"47","author":"Stein","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.ajg.2013.08.005_b0175","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1478-3231.2006.01306.x","article-title":"Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study","volume":"26","author":"Tsamandas","year":"2006","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.ajg.2013.08.005_b0180","first-page":"368","article-title":"Promotion of growth and differentiation of rat ductular oval cells in primary culture","volume":"48","author":"Germain","year":"1988","journal-title":"Cancer Res"},{"issue":"51(10)","key":"10.1016\/j.ajg.2013.08.005_b0185","first-page":"2611","article-title":"Cell lineages and oval cell progenitors in rat liver development","volume":"15","author":"Shiojiri","year":"1991","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ajg.2013.08.005_b0190","first-page":"1606","article-title":"Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration","volume":"143","author":"Dabeva","year":"1993","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ajg.2013.08.005_b0195","first-page":"65","article-title":"Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CCl4\/2-AAF injury","volume":"17","author":"Yin","year":"2002","journal-title":"Histol Histopathol"},{"issue":"6","key":"10.1016\/j.ajg.2013.08.005_b0200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1478-3231.2004.0976.x","article-title":"Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4","volume":"24","author":"Alfaleh","year":"2004","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.ajg.2013.08.005_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2036.2003.01463.x","article-title":"Review article: indicators and predictors of response to antiviral therapy in chronic HCV","volume":"17","author":"Lee","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197913001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197913001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T16:26:30Z","timestamp":1746030390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197913001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1687197913001226"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2013.08.005","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}